Dr. Yehia Hashad Will Join Bausch + Lomb Corporation as Executive Vice President of Research & Development and Chief Medical Officer

/PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") has announced that Dr. Yehia Hashad will join Bausch + Lomb Corporation ("Bausch...

Related Keywords

Canada ,New Jersey ,United States ,France ,Canadian ,Lainie Keller ,Josephc Papa ,Allergan Abbvie ,Arthur Shannon ,National Alliance Of Eye ,Instagram ,Linkedin ,Twitter ,University Of California Irvine Research Center ,Research Development ,Lomb Corporation Bausch ,Glaucoma Research Foundation ,Allergan ,Facebook ,Clinical Development ,Bausch Health ,A Pharma Group ,Bausch Health Companies Inc ,Global Clinical Development ,Cairo University ,Exchange Commission ,Prnewswire Bausch Health Companies Inc ,Vision Research ,Health Companies ,Yehia Hashad ,Lomb Corporation ,Novartis Pharma ,Pharma Group ,Allergan Aesthetics ,Medical Aesthetics ,Surgical Ophthalmology ,National Alliance ,California Irvine Research ,Bausch Health Companies ,Canadian Securities Administrators ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Pharmaceuticals ,Medical Equipment ,Personnel Announcements ,